Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
61 (5%)
Anticipated shortage:
0 (0%)
Avoided shortage:
36 (3%)
Resolved:
1223 (93%)
1320
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
283 (99%)
Reversed:
2 (1%)
287
211 (13%)
35 (56%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
| PMS-BUPRENORPHINE-NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2024-07-24 | 2024-10-09 | 233605 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-19 | 8925 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-08-11 | 2018-05-05 | 18860 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2017-09-19 | 2018-04-19 | 22744 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2017-10-12 | 2018-04-19 | 25743 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2017-10-12 | 2018-02-17 | 25746 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2019-11-15 | 2020-05-19 | 98802 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2021-07-29 | 2021-08-30 | 143172 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2023-04-14 | 2023-08-17 | 189598 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-15 | 2024-07-10 | 222369 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2020-06-17 | 2020-06-17 | 118093 |
| PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117714 |
| PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-06-21 | 2021-06-21 | 141302 |
| PMS-DOCUSATE SODIUM | 250MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117730 |
| PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149365 |
| PMS-DOCUSATE SODIUM DROPS 10MG/ML | 10MG | DROPS DROPS | Discontinued | 2020-06-15 | 2021-10-27 | 117733 |
| PMS-DOMPERIDONE | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117760 |
| PMS-DORZOLAMIDE-TIMOLOL | 20MG 5MG | SOLUTION | Discontinued | 2020-06-16 | 2020-06-16 | 118026 |
| PMS-DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2022-12-09 | 2022-12-09 | 177691 |
| PMS-DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2022-12-09 | 2022-12-09 | 177694 |
| PMS-ELETRIPTAN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117933 |
| PMS-ELETRIPTAN | 40MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118162 |
| PMS-ELETRIPTAN | 40MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118165 |
| PMS-ENALAPRIL | 16MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6041 |
| PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6044 |
| PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6047 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149400 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2019-06-28 | 2019-06-28 | 87934 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2019-06-28 | 2019-06-28 | 87938 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149403 |